Literature DB >> 16809555

Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype.

Claes Ladenvall1, Katarina Jood, Christian Blomstrand, Staffan Nilsson, Christina Jern, Per Ladenvall.   

Abstract

BACKGROUND AND
PURPOSE: C-reactive protein (CRP) has evolved as an inflammatory risk marker of cardiovascular disease. Several single-nucleotide polymorphisms at the CRP locus have been found to be associated with CRP levels. The aim of the present study was to investigate CRP levels and genetic variants in etiological subtypes of ischemic stroke.
METHODS: The Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS) comprises 600 consecutive ischemic stroke cases (18 to 69 years) and 600 matched controls from western Sweden. Stroke subtypes were defined by the TOAST classification. Serum CRP levels were determined by a high-sensitivity immunometric assay.
RESULTS: CRP levels were significantly higher for all ischemic stroke subtypes compared with controls, both in the acute phase and at the 3-month follow-up. After adjustment for traditional risk factors, CRP at follow-up was related to higher odds ratios (ORs) of overall ischemic stroke (OR, 1.25; 95% CI, 1.09 to 1.43) and large-vessel disease (OR, 1.48; 95% CI, 1.09 to 2.00). The CRP -286C>T>A, 1059G>C, and 1444C>T single-nucleotide polymorphisms showed significant associations with CRP levels. However, neither CRP genotypes nor haplotypes showed an association to overall ischemic stroke.
CONCLUSIONS: This is the first large study on CRP in different TOAST subtypes in a young ischemic stroke population. CRP levels differed between etiological subtypes of ischemic stroke both in the acute phase and at the 3-month follow-up. CRP at follow-up was associated with overall ischemic stroke and the large-vessel disease subtype. Genetic variants at the CRP locus were associated with CRP levels, but no association was detected for overall ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809555     DOI: 10.1161/01.STR.0000231872.86071.68

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  41 in total

1.  Regional brain shrinkage over two years: individual differences and effects of pro-inflammatory genetic polymorphisms.

Authors:  N Persson; P Ghisletta; C L Dahle; A R Bender; Y Yang; P Yuan; A M Daugherty; N Raz
Journal:  Neuroimage       Date:  2014-09-28       Impact factor: 6.556

Review 2.  Potential serum biomarkers in the pathophysiological processes of stroke.

Authors:  Yanying Miao; James K Liao
Journal:  Expert Rev Neurother       Date:  2014-01-13       Impact factor: 4.618

3.  C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome.

Authors:  K Rajeshwar; Subhash Kaul; Amal Al-Hazzani; M Sai Babu; N Balakrishna; Vandana Sharma; A Jyothy; Anjana Munshi
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 4.  Brain-kidney interaction: Renal dysfunction following ischemic stroke.

Authors:  Qiang Zhao; Tao Yan; Michael Chopp; Poornima Venkat; Jieli Chen
Journal:  J Cereb Blood Flow Metab       Date:  2019-11-25       Impact factor: 6.200

5.  CRP gene (1059G>C) polymorphism and its plasma levels in ischemic stroke and hemorrhagic stroke in a south Indian population.

Authors:  Satrupa Das; Sitara Roy; Subhash Kaul; Akka Jyothy; Anjana Munshi
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

6.  GWAS-Supported CRP Gene Polymorphisms and Functional Outcome of Large Artery Atherosclerotic Stroke in Han Chinese.

Authors:  Zusen Ye; Hao Zhang; Lingli Sun; Huan Cai; Yonggang Hao; Zongliang Xu; Zhizhong Zhang; Xinfeng Liu
Journal:  Neuromolecular Med       Date:  2018-03-19       Impact factor: 3.843

7.  C-reactive protein and aetiological subtypes of cerebral infarction.

Authors:  Alessandro Terruzzi; Laura Valente; Roberto Mariani; Luca Moschini; Massimo Camerlingo
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

Review 8.  The immune system in stroke: clinical challenges and their translation to experimental research.

Authors:  Craig J Smith; Catherine B Lawrence; Beatriz Rodriguez-Grande; Krisztina J Kovacs; Jesus M Pradillo; Adam Denes
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-15       Impact factor: 4.147

9.  Diabetes increases large artery diseases, but not small artery diseases in the brain.

Authors:  Beom Joon Kim; Seung-Hoon Lee; Bong Su Kang; Byung-Woo Yoon; Jae-Kyu Roh
Journal:  J Neurol       Date:  2008-06-13       Impact factor: 4.849

10.  C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death.

Authors:  H M den Hertog; J A van Rossum; H B van der Worp; H M A van Gemert; R de Jonge; P J Koudstaal; D W J Dippel
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.